INTERNATIONAL PATENT: VECTORGEN FILES APPLICATION FOR "LENTIVIRAL VECTOR FOR TREATING HUMAN IMMUNODEFICIENCY VIRUS INFECTION"

GENEVA, Feb. 24 -- VECTORGEN (5 Hall Place, Apt. BAlbany, New York 12210) filed a patent application (PCT/US2025/041365) for "LENTIVIRAL VECTOR FOR TREATING HUMAN IMMUNODEFICIENCY VIRUS INFECTION" on Aug 08, 2025. With publication no. WO/2026/039311, the details related to the patent application was published on Feb 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PRENDERGAST, Laura A. (5 Hall Place, Apt. BAlbany, New York 12210)

Abstract: Provided herein are a vector for eradicating human immunodeficiency virus (HIV) from a human comprising a nucleic acid sequence encoding a dual-functi...